Positron Emission Tomography of Human Hepatocellular Carcinoma Xenografts in Mice Using Copper (II)-64 Chloride as a Tracer with Copper (II)-64 Chloride

Academic Radiology

Volumn 18, Issue 12, 2011, Pages 1561-1568

  Zhang, Haiyuan ^d   Cai, Huawei ^a   Lu, Xin ^d   Muzik, Otto ^d   Peng, Fangyu ^a,b,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Copper metabolism; Copper(II) 64 chloride; Hepatocellular carcinoma; Human copper transporter 1; Positron emission tomography

Indexed keywords

COPPER II 64 CHLORIDE; COPPER PROTEIN; COPPER TRANSPORTER 1; TRACER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CANCER CELL; CANCER TISSUE; CONTROLLED STUDY; COPPER METABOLISM; EMBRYO; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RADIOACTIVITY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHOULDER; TUMOR XENOGRAFT;

ANIMALS; CARCINOMA, HEPATOCELLULAR; COPPER; COPPER RADIOISOTOPES; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; POSITRON-EMISSION TOMOGRAPHY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 80055111661     PISSN: 10766332     EISSN: 18784046     Source Type: Journal    
DOI: 10.1016/j.acra.2011.08.006     Document Type: Article

References (33)

1. Parkin D.M., Pisani P., Ferlay J. Global cancer statistics. CA Cancer J Clin 1999, 49:33-64.
2. Pisani P., Parkin D.M., Bray F.J., et al. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999, 83:18-29.
3. Lee Y.T., Geer A.D. Primary liver cancer: pattern of metastasis. J Surg Oncol 1987, 36:26-31.
4. Stuart K.E., Anand A.J., Jenkins R.L. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer 1996, 77:2217-2222.
5. Yen F.S., Wu J.C., Lai C.R., et al. Clinical and radiological pictures of hepatocellular carcinoma with intracranial metastasis. J Gastroenterol Hepatol 1995, 10:413-418.
6. Chang L., Chen Y.L., Kao M.C. Intracranial metastasis of hepatocellular carcinoma: review of 45 cases. Surg Neurol 2004, 62:172-177.
7. Zornig C., Broelsch C.E. Impact of staging on the treatment of hepatocellular carcinoma. Endoscopy 1993, 25:138-142.
8. Som P., Atkins H.L., Bandoypadhyay D., et al. A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose [18F]: nontoxic tracer for rapid tumor detection. J Nucl Med 1980, 21:670-675.
9. Trojan J., Schroeder O., Raedle J., et al. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma. Am J Gastroenterol 1999, 94:3314-3319.
10. Puig S., Thiele D.J. Molecular mechanisms of copper uptake and distribution. Curr Opin Chem Biol 2002, 6:171-180.
11. Zhou B., Gitschier J. hCTR1: a human gene for copper uptake identified by complementation in yeast. Proc Natl Acad Sci U S A 1997, 94:7481-7486.
12. Chelly J., Tumer Z., Tonnesen T., et al. Isolation of a candidate gene for Menkes disease that encodes a potential heavy metal binding protein. Nat Genet 1993, 3:14-19.
13. Bull P.C., Thomas G.R., Rommens J.M., et al. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 1993, 5:327-337.
14. Klomp L.W., Lin S.J., Yuan D.S., et al. Identification and functional expression of HAH1, a novel human gene involved in copper homeostasis. J Biol Chem 1997, 272:9221-9226.
15. Amaravadi R., Glerum D.M., Tzagoloff A. Isolation of a cDNA encoding the human homolog of COX17, a yeast gene essential for mitochondrial copper recruitment. Hum Genet 1997, 99:329-333.
16. Culotta V.C., Klomp L.W.J., Strain J. The copper chaperone for superoxide dismutase. J Biol Chem 1997, 199:23469-23472.
17. Theophanides T., Anastassopoulou J. Copper and carcinogenesis. Crit Rev Oncol Hematol 2002, 1:57-64.
18. Margalioth E.J., Schenker J.G., Chevion M. Copper and zinc levels in normal and malignant tissues. Cancer 1983, 5:868-872.
19. Diez M., Arroyo M., Cerdan F.J., et al. Serum and tissue trace metal levels in lung cancer. Oncology 1989, 4:230-234.
20. Peng F., Liu J., Wu J.S., et al. Mouse extra-hepatic hepatoma detected on microPET using copper (II)-64 chloride uptake mediated by endogenous mouse copper transporter 1. Mol Imaging Biol 2005, 7:325-329.
21. Peng F., Lu X., Janisse J., et al. Positron emission tomography of human prostate cancer xenografts in mice with increased uptake of copper (II)-64 chloride. J Nucl Med 2006, 47:1649-1652.
22. Hudson H.M., Larkin R.S. Accelerated image reconstruction using ordered subsets of projection data. IEEE Trans Med Imaging 1994, 13:601-609.
23. Woodard H.Q., Gigler R.E., Freed B., et al. Expression of tissue isotope distribution. J Nucl Med 1975, 16:958-959.
24. Xie D., Gore C., Liu J., et al. Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis. Proc Natl Acad Sci U S A 2010, 107:2485-2490.
25. Osborn S.B., Szaz K.F., Walshe J.M. Studies with radioactive copper (64Cu and 67Cu): abdominal scintiscans in patients with Wilson's disease. Q J Med 1969, 38:467-474.
26. Walshe J.M., Potter G. The pattern of the whole body distribution of radioactive copper (67Cu, 64Cu) in Wilson's disease and various control groups. Q J Med 1977, 46:445-462.
27. Skromne-Kadlubik G., Diaz J.F., Celis C. Basal ganglia scans in the human. J. Nucl Med 1975, 16:787-788.
28. Sternlieb I., Scheinberg I.H. Radiocopper in diagnosing liver disease. Semin Nucl Med 1972, 2:176-188.
29. Blower P.J., Lewis J.S., Zweit J. Copper radionuclides and radiopharmaceuticals in nuclear medicine. Nucl Med Biol 1996, 23:957-980.
30. Peng F, Lutsenko S, Sun X, et al. Positron emission tomography of copper metabolism in the Atp7b-/- knock-out mouse model of Wilson's disease. Mol Imaging Biol. In press.
31. Holzer A.K., Varki N.M., Le Q.T., et al. Expression of the human copper influx transporter 1 in normal and malignant human tissues. J Histochem Cytochem 2006, 54:1041-1049.
32. Yoshi J., Yoshi H., Kuriyama S., et al. The copper-chelating agent, trientine, suppresses tumor development and angiogenesis in the murine hepatocellular carcinoma cells. Int J Cancer 2001, 94:768-773.
33. Moriguchi M., Nakajima T., Kimura H., et al. The copper chelator trientine has an antiangiogenic effect against hepatocellular carcinoma, possibly through inhibition of interleukin-8 production. Int J Cancer 2002, 102:445-452.